Dolutegravir Sodium CAS NO1051375-19-9

Khoom Qhia:

Khoom Siv Lub Npe: Dolutegravir Sodium CAS TSIS TAU: 1051375-19-9

Txhais:

Sodium (4R, 12aS) -9 - ((2,4-difluorobenzyl) carbamoyl) -4-methyl-6,8-Dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1', 2': 4,5] pyrazino [2,1-b] [1,3] oxazin-7-olate;

sodium, (4R, 12aS) -9 - [(2,4-difluorophenyl) methylcarbamoyl] -4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido [5,6] pyrazino [2,6-b] [1,3] oxazin-7-olate;

(4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1', 2': 4,5] pyrazino- [2,1-b] [1,3] oxazine-9-carboxamide sodium ntsev;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: hmoov daj ntseg daj

Ntsuas: ≥99.0%

Dolutegravir Sodium yog lub cim thib ob tiam HIV-1 integrase saw hloov mus rau lwm qhov. Dolutegravir Sodium tam sim no nyob rau theem III kev sim tshuaj rau kev kho tus mob HIV. Nws tau qhia tias Dolutegravir Sodium tuaj yeem tiv thaiv kab mob HIV rov qab ua haujlwm hauv cov kab mob kis tus kabmob PHIV Lentiviral tsis ua haujlwm, xws li peripheral ntshav mononuclear cells (PBMC), MT-4 hlwb thiab CIP4 hlwb.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: dolutegravir sodium cas no1051375-19-9, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: Mirabegron CAS 223673-61-8
• Tom ntej: 3-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid CAS 162401-62-9